Does TACROLIMUS Cause Haemolytic anaemia? 152 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Haemolytic anaemia have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.2% of all adverse event reports for TACROLIMUS.
152
Reports of Haemolytic anaemia with TACROLIMUS
0.2%
of all TACROLIMUS reports
28
Deaths
77
Hospitalizations
How Dangerous Is Haemolytic anaemia From TACROLIMUS?
Of the 152 reports, 28 (18.4%) resulted in death, 77 (50.7%) required hospitalization, and 22 (14.5%) were considered life-threatening.
Is Haemolytic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 152 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Haemolytic anaemia?
HUMAN IMMUNOGLOBULIN G (408)
RIBAVIRIN (263)
RITUXIMAB (221)
CARBOPLATIN (167)
METHYLPREDNISOLONE (157)
METFORMIN (154)
OXALIPLATIN (141)
ACETAMINOPHEN (137)
PREDNISONE (131)
CEFTRIAXONE (129)
Which TACROLIMUS Alternatives Have Lower Haemolytic anaemia Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB